Reversible electroporation is not painful. You may feel a slight tingling sensation and sometimes a temporary metallic taste in your mouth during the application. These effects are mild, harmless, and disappear quickly after the session.

For plasma treatment, an anesthetic cream is often sufficient to prevent any pain. In cases of deeper emoval, a small injection of anesthetic may be administered. With the cream alone, the sensation is generally one of tingling or localized warmth.

With reversible electroporation, patients notice that their skin or mucous membranes are more supple, less red, less dry, and show lasting improvement, lasting from six months to a year depending on the case and type of condition. A maintenance session is recommended every 6 months.

Plasma treatments firm, cleanse, and regenerate tissue, with visible results sometimes apparent after just one session. The after-effects are minor: slight redness and fine flaking, with no deep scarring. As a general rule, a single session is sufficient. For certain areas, such as the eyelids, a second session may be considered over time.

The Jett technology offers much greater versatility compared to Radio Frequency (RF) and Intense Pulsed Light (IPL) because it combines complex actions, particularly for direct applications of pulsed direct current.
RF and IPL mainly rely on heat emission and gland expression to treat Meibomian Gland Dysfunction (MGD), stimulate collagen, and heat the Meibomian glands, Jett goes further. It also affects several other aspects of the ocular surface, influencing various mechanisms that contribute to dry eye and inflammatory conditions.
Jett technology directly stimulates the goblet cells responsible for mucin production, reducing excessive evaporation and contributing to better lubrication of the eye. It also supports the proper function of the orbicularis muscle to improve blink efficiency, which is essential for the even distribution of tears. By acting on the laxity of the lower eyelids and the Riolan muscle, it optimizes eyelid closure and tear distribution, thus reducing dryness.
Furthermore, with its new protocols, Jett stimulates the accessory lacrimal glands of Krause and Wolfring, which are responsible for producing the aqueous component of the tear film, promoting optimal aqueous secretion. It also strengthens local conjunctival immunity, an essential system for protecting the ocular surface. Finally, it acts on cell regeneration, improves meibum quality, and creates an astringent effect that enhances the function of the Meibomian glands. These combined mechanisms allow for a comprehensive, non-invasive management of dry eye and inflammation control.